Prosecution Insights
Last updated: November 04, 2026

Haleon (Suzhou) Pharmaceutical Co. Ltd.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Haleon (Suzhou) Pharmaceutical Co. Ltd. is active in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This activity is distributed across 1 distinct examiner and 1 distinct art unit, indicating a specialized and focused prosecution phase. The presence of 1 pending office action within a single art unit suggests that the company is pursuing a specific pharmaceutical or biotechnological innovation rather than a broad array of diverse technologies. This concentration allows for a targeted approach to claim amendments and arguments.

The busiest examiner for this portfolio is WERTZ, ASHLEE ELIZABETH, who is managing 1 busiest examiner pending action. Because 1 distinct examiner is handling the entirety of the pending workload, the prosecution strategy is inherently centralized. Practitioners can focus their efforts on the specific requirements and historical preferences of this 1 examiner to resolve the 1 pending office action. This streamlined interaction reduces the complexity often found in larger portfolios where various examiners might issue different requirements across various applications.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WERTZ, ASHLEE ELIZABETH 1 49.1% +40.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18291716 IMPROVED MANUFACTURING PROCESS WERTZ, ASHLEE ELIZABETH —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18291716 IMPROVED MANUFACTURING PROCESS WERTZ, ASHLEE ELIZABETH —

Top Art Units

Art UnitApps
1612 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18291716 IMPROVED MANUFACTURING PROCESS WERTZ, ASHLEE ELIZABETH 1612 §103§112 Non-Final OA — Pending Jan 24, 2024

Managing Haleon (Suzhou) Pharmaceutical Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Haleon (Suzhou) Pharmaceutical Co. Ltd. have?

Haleon (Suzhou) Pharmaceutical Co. Ltd. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Haleon (Suzhou) Pharmaceutical Co. Ltd. applications?

Ashlee Elizabeth Wertz has the most, with 1 of Haleon (Suzhou) Pharmaceutical Co. Ltd.'s pending office actions.

What technology area are Haleon (Suzhou) Pharmaceutical Co. Ltd.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month